Skip to content

Author

Victor Arinze Orajekwe

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

First Antibacterial Evaluation of an Anthraquinone–triphenylphosphonium Conjugate (SH1) against Sensitive and Drug-resistant Staphylococcus aureus and Escherichia coli

The results identify SH1 as a previously uncharacterised antibacterial agent active against MRSA and support the anthraquinone–DLC pharmacophore as a membrane-active scaffold warranting further structural optimisation.

Victor Arinze Orajekwe · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.